Trevi Therapeutics, Inc.

TRVI - CIK 0001563880

Market cap$1.90 B

Rank#2129

SEC filings524

TRVI balance sheet (annual)

The table below shows Trevi Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$18.91M	$34.10M	$32.40M	$12.59M	$36.83M	$45.00M
Short-term investments	$169.35M	$73.53M	$50.57M	$107.92M	-	-
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.